Institutional orthopedic liability forecasting. Solve for implant failure potentials, device loosening, and revision surgery benchmarks.
MDL DATA
2026 Statutory Sync
| Metric | Verification |
|---|---|
| Failure Rate | Up to 25% at 10 years |
| Annual Revisions | 5000+ |
| Litigation Status | Active Litigation |
| Category | Avg Settlement |
|---|---|
| Revision Surgery Required | $175,000 |
| Component Loosening | $125,000 |
| Ankle Fusion Required | $200,000 |
| Factor | Multiplier |
|---|---|
| Revision Required | 2.5x Base |
| Permanent Fusion | 3.0x Max |
| Audit Version | S-Class v2.6 |
Ankle implant liability is governed by **Device Integrity Protocols**. Our engine audits recovery potentials based on device brand failure rates, revision surgery complexity, and current medical tort settlement protocols.
Audit of component loosening logs
FDA MAUDE Database alignment
AAOS Registry statutory sync
"Calibrated against 2026 FDA MAUDE reports, AAOS clinical guidelines, and orthopedic medical liability benchmarks."
A: Lawsuits allege that certain total ankle replacement devices have high failure rates, causing premature loosening, bone loss, and requiring revision surgery or permanent ankle fusion.
A: In 2026, settlements range from $125,000 for complex cases to over $200,000 if ankle fusion or multiple revision surgeries were required due to device failure.
A: Litigation has focused on several brands, including Wright Medical (INBONE), Integra (SALTO), and DePuy (STAR), often citing higher-than-average failure rates in the FDA MAUDE database.
Don't let medical device failure go uncompensated. Initiate your official S-Class forensic ankle implant liability audit.
INITIATE AUDIT NOW